The Role of Nanoparticle PEGylation in Drug Delivery

2020

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.17277/amt.2020.02.pp.010-018
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Over the past few decades, nanoparticles have been attracting significant attention of researches in chemical, biomedical, pharmaceutical sciences, due to their unique physicochemical properties.This includes ultra small size, large surface area, good biocompatibility and high reactivity.In particular, nanoparticles are promising for pharmaceutical and biomedical fields, as they have been applied as drug carriers and diagnostic tools.However, nanoparticles can be easily detected and cleared out by the mononuclear phagocyte system before delivering the drug to the target site.One of the most widely applied approaches to prolong circulation of nanoparticles is to modify their surfaces with polyethylene glycol (PEG).This paper describes how PEGylation occurs, as well as application of various PEGylated nanoparticles in drug delivery.